Effect of neoadjuvant therapy on breast cancer biomarker profile

Effect of neoadjuvant therapy on breast cancer biomarker profile

Abstract Background Breast cancer clinical management requires the assessment of hormone receptors (estrogen (ER) and progesterone receptor (PR)), human epidermal growth factor receptor 2 (HER2) and cellular proliferation index Ki67, by immunohistochemistry (IHC), in order to choose and guide therap...

Full description

Bibliographic Details
Main Authors: Laura Rey-Vargas, Juan Carlos Mejía-Henao, María Carolina Sanabria-Salas, Silvia J. Serrano-Gomez
Format: Article
Language:English
Published: BMC 2020-07-01
Series:BMC Cancer
Subjects:
Breast neoplasms
Immunohistochemistry
Neoadjuvant therapy
Biomarkers
Heterogeneity
Online Access:http://link.springer.com/article/10.1186/s12885-020-07179-4

Internet

http://link.springer.com/article/10.1186/s12885-020-07179-4

Similar Items